\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ surgery\\ only\ \(3\)\
\-\ third\\ ventricular\\ mass\\ with\\ associated\\ hydrocephalus\\.\ \(0\)\
\-\ mass\\ enhances\\ following\\ contrast\\ administration\\.\ \(1\)\
\-\ tanycytic\\ ependymoma\ \(1\)\
\-\ \\â\\€\\¢\\ ependymoma\ \(8\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ choroid\\ plexus\\ papilloma\ \(4\)\
\-\ \\â\\€\\¢\\ astrocytoma\ \(1\)\
\-\ \\â\\€\\¢\\ central\\ neurocytoma\ \(2\)\
\-\ 27\\ year\\ old\\ female\\ referred\\ to\\ neurosurgery\\ with\\ third\\ ventricular\\ tumor\ \(0\)\
\-\ the\\ \\"tanycytic\\ ependymoma\\"\\ is\\ an\\ uncommon\\ subtype\\ of\\ ependymoma\\ with\\ a\\ fibrillary\\ appearance\\ and\\ piloid\\ or\\ \\"hair\\-like\\"\\ cells\\.\\ \\ rosette\\ formation\\ is\\ rare\\ compared\\ to\\ other\\ types\\ of\\ ependymoma\\.\\ \\ the\\ prognosis\\ is\\ probably\\ similar\\ to\\ other\\ ependymomas\\.\\ \\ pmid\\:\\ 15690137\ \(0\)\
\-\ http\\:\\/\\/www\\.ncbi\\.nlm\\.nih\\.gov\\/pubmed\\/9090024\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ependymoma\\:\\ 0\\.21016955149383307\ \(0\)\
\-\ tanycytic\\:\\ 0\\.1937476576695934\ \(0\)\
\-\ piloid\\:\\ 0\\.0968738288347967\ \(0\)\
\-\ hair\\-like\\:\\ 0\\.0968738288347967\ \(0\)\
\-\ 15690137\\:\\ 0\\.0968738288347967\ \(0\)\
\-\ \\/\\/www\\.ncbi\\.nlm\\.nih\\.gov\\/pubmed\\/9090024\\:\\ 0\\.0968738288347967\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.0860996896481257\ \(0\)\
\-\ rosette\\:\\ 0\\.08480116632196032\ \(0\)\
\-\ ventricular\\:\\ 0\\.08391881648796447\ \(0\)\
\-\ fibrillary\\:\\ 0\\.07918769792892745\ \(0\)\
\-\ third\\:\\ 0\\.0753065207505494\ \(0\)\
\-\ ependymomas\\:\\ 0\\.07157069594475222\ \(0\)\
\-\ subtype\\:\\ 0\\.06341753831036347\ \(0\)\
\-\ neurocytoma\\:\\ 0\\.059498033431915856\ \(0\)\
\-\ pmid\\:\\ 0\\.05913770570858629\ \(0\)\
\-\ neurosurgery\\:\\ 0\\.052837200425648656\ \(0\)\
\-\ probably\\:\\ 0\\.050031192823353665\ \(0\)\
\-\ choroid\\:\\ 0\\.0479249574473955\ \(0\)\
\-\ types\\:\\ 0\\.0479249574473955\ \(0\)\
\-\ papilloma\\:\\ 0\\.04718384447162042\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.04615681401388609\ \(0\)\
\-\ uncommon\\:\\ 0\\.04594274105205344\ \(0\)\
\-\ plexus\\:\\ 0\\.045627245383015734\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.04526921982378556\ \(0\)\
\-\ prognosis\\:\\ 0\\.04454224713372244\ \(0\)\
\-\ enhances\\:\\ 0\\.04435598825115351\ \(0\)\
\-\ 27\\:\\ 0\\.043554814945570126\ \(0\)\
\-\ other\\:\\ 0\\.04328875931214173\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.04037203151059163\ \(0\)\
\-\ compared\\:\\ 0\\.039747487831875525\ \(0\)\
\-\ administration\\:\\ 0\\.038985277636298575\ \(0\)\
\-\ formation\\:\\ 0\\.03876100432166993\ \(0\)\
\-\ cells\\:\\ 0\\.0376532603752747\ \(0\)\
\-\ similar\\:\\ 0\\.036831721087262514\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.036465386798607655\ \(0\)\
\-\ rare\\:\\ 0\\.036465386798607655\ \(0\)\
\-\ meningioma\\:\\ 0\\.036110871829176654\ \(0\)\
\-\ http\\:\\ 0\\.03555811646132172\ \(0\)\
\-\ referred\\:\\ 0\\.03543441146654551\ \(0\)\
\-\ non\\-contributory\\:\\ 0\\.03468171657370195\ \(0\)\
\-\ central\\:\\ 0\\.03089704787758197\ \(0\)\
\-\ only\\:\\ 0\\.02823529295038391\ \(0\)\
\-\ appearance\\:\\ 0\\.026856116227853204\ \(0\)\
\-\ following\\:\\ 0\\.026651403921990644\ \(0\)\
\-\ mass\\:\\ 0\\.026120022130715705\ \(0\)\
\-\ \\:\\:\\ 0\\.024841204747047586\ \(0\)\
\-\ surgery\\:\\ 0\\.022802187520442583\ \(0\)\
\-\ associated\\:\\ 0\\.02215892925173299\ \(0\)\
\-\ tumor\\:\\ 0\\.02189266265506386\ \(0\)\
\-\ contrast\\:\\ 0\\.021019513041845114\ \(0\)\
\-\ female\\:\\ 0\\.019305057927998172\ \(0\)\
\-\ is\\:\\ 0\\.018537058628067878\ \(0\)\
\-\ to\\:\\ 0\\.014079168410208339\ \(0\)\
\-\ an\\:\\ 0\\.012985328178953075\ \(0\)\
\-\ or\\:\\ 0\\.011005744494106677\ \(0\)\
\-\ year\\:\\ 0\\.01050665131069137\ \(0\)\
\-\ old\\:\\ 0\\.009614665899585217\ \(0\)\
\-\ a\\:\\ 0\\.00435823958042419\ \(0\)\
\-\ with\\:\\ 0\\.0038572805304359255\ \(0\)\
\-\ the\\:\\ 0\\.003038445817662106\ \(0\)\
\-\ of\\:\\ 0\\.002560523094461284\ \(0\)\
\-\ and\\:\\ 0\\.001978120942112291\ \(0\)\
\-\ \\.\\:\\ 0\\.0019505239613926524\ \(0\)\
